Bruna, J., Videla, S., Argyriou, A., Velasco, R., Villoria, J., Vaqué, ., et al. (2016). MR309/E-52862, a first-in-class sigma-1 receptor antagonist, in oxaliplatin-induced peripheral neuropathy. An exploratory Phase II clinical trial. In Abstract Book of "16th World Congress on pain 2016 International Association for the Study of pain".
MR309/E-52862, a first-in-class sigma-1 receptor antagonist, in oxaliplatin-induced peripheral neuropathy. An exploratory Phase II clinical trial
CAVALETTI, GUIDO ANGELO;ALBERTI, PAOLA;CORTINOVIS, DIEGO LUIGI;
2016
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
